Associated Papers
Beyond environmental risk: Genetic insights into lung cancer susceptibility through whole exome analysis.
Lintas C et al.
Lung Cancer (amsterdam, Netherlands), 2025
Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course.
Akhoundova D et al.
Diagnostic Pathology, 2024
38907236 (PubMed )
Supplement: 13000_2024_1511_MOESM1_ESM.xlsx › Supp_Table_1
Mendelian gene identification through mouse embryo viability screening.
Cacheiro P et al.
Genome Medicine, 2022
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA et al.
Acta Neuropathologica Communications, 2020
33087175 (PubMed )
Supplement: 40478_2020_1040_MOESM1_ESM.xlsx › Sheet1
Lack of evidence for CDK12 as an ovarian cancer predisposing gene.
Eeckhoutte A et al.
Familial Cancer, 2020
CDK12: A Potent Target and Biomarker for Human Cancer Therapy.
Liang S et al.
Cells, 2020
A Splice Site Variant of CDK12 and Breast Cancer in Three Eurasian Populations.
Bogdanova NV et al.
Frontiers in Oncology, 2019
The Ethnic-Specific Spectrum of Germline Nucleotide Variants in DNA Damage Response and Repair Genes in Hereditary Breast and Ovarian Cancer Patients of Tatar Descent.
Brovkina OI et al.
Frontiers in Oncology, 2018
Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity.
Saleheen D et al.
Nature, 2017
28406212 (PubMed )
Supplement: NIHMS857566-supplement-Suppl__Table_1.xlsx › Supplementary_Table_1
Select a paper to view details